bioRxivCancer BiologyPreprint
Malignant tumors engender and employ cancer-specific organelles for self-protection and metastasis
Abstract
Cancer is a leading source of human lethality but current therapies have had limited efficacy in many cancers, which highlights an unmet need to assess the underlying mechanisms that govern cancer progression in vivo. Here we show that, upon malignant transformation, aggressive oncocells generate extracellular membranous compartments, cytocapsulas or cytocapsular tubes (CCTs), to enclose oncocells and engender cytocapsular oncocells in vivo. Cytocapsular oncocells are universally present in solid cancers and appear in hematologic cancers in the immune organs. Networks of cytocapsular tubes provide membrane-enclosed freeways for protected cancer metastasis. CCT networks interconnect cytocapsular tumors creating cytocapsular tumor network systems. Our findings suggest that cytocapsular oncocells drive membrane-encompassed cancer progression. Thus, interconnected cytocapsular oncocells, CCT networks and cytocapsular tumor network systems coordinate cancer progression in the integrated cytocapsular membrane systems.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cytocapsular cancer evolution analyses of 311 kinds of cancers
- Cancer Metastases of 202 Kinds of Cancers via Cytocapsular Tubes
- Nanoprotrusion enlargement conducts cytocapsular tube elongation along the path of least resistance for metastasis initiation
Tingfang Yi, Gerhard Wagner·bioRxiv·Feb 10, 2025
- Cytocapsulae and cytocapsular tubes are golden targets for precise, effective and efficient cancer diagnosis and therapy in 307 kinds of liquid and solid cancers
- Cytocapsular tube network-tumor system is an integrated physical target for the highly effective and efficient pharmacotherapy of solid cancers
- Glycocalyx-Mediated Vascular Dissemination of Circulating Tumor Cells
G. Offeddu, C. Hajal, … R. Kamm·bioRxiv·Apr 28, 2020